Flagship explainer
What drives TELA Bio, Inc.’s return on equity?
ROE is five filed business factors multiplied together.
| Input | Value | Fiscal year | Source |
|---|---|---|---|
| −$38.8M | FY2025 |
| |
| Income before tax | −$38.6M | FY2025 |
|
| Operating income | −$33.8M | FY2025 |
|
| $80.3M | FY2025 |
| |
| Ending assets | $81.4M | FY2025 |
|
| Beginning assets | $86.6M | FY2024 |
|
| $6.3M | FY2025 |
| |
| $28.5M | FY2024 |
|
Source:
- SEC filingFiling detailsAccession 0001104659-26-034507